Humanitarian Use Device-Cancer-Liver-Radiology Treatment-TheraSphere®
| Title | Treatment of unresectable primary or unresectable secondary liver cancer with TheraSphere® |
|---|---|
| Description | TheraSphere® is a medical device containing Yttrium-90 (Y-90), a radioactive material that has been used to treat liver tumors. When Y-90 is put into very tiny glass microspheres (TheraSphere®), injected into the liver through a blood vessel, it allows a large local dose of radiation to be delivered to the tumor with less risk of toxic effects from radiation treatment to other parts of the body or to healthy liver tissue. The radiation from TheraSphere® is contained within the body and becomes minimally active within 12 days after treatment due to physical decay. The glass microspheres remain in the body, but should not cause any health problems. |
| NCT Number | 00701168 |
| Start Date | 06/01/2015 |
| Status | Active |
| Principal Name | Matthew Moore, MD |
| Phone | (208)384-9060 |